We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
PhRMA is urging the FDA to withdraw or scale back its Part 11 regulation in favor of other more recently approved legislation addressing electronic records, arguing that the rule is too prescriptive and the cost of compliance too high.